Pfizer Inc. - Net Worth and Insider Trading
Pfizer Inc. Net Worth
The estimated net worth of Pfizer Inc. is at least $277 Million dollars as of 2025-04-11. Pfizer Inc. is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals and owns about 115,928,803 shares of CStone Pharmaceuticals (HKSE:02616) stock worth over $277 Million. Details can be seen in Pfizer Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pfizer Inc. has not made any transactions after 2020-10-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pfizer Inc.
Pfizer Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pfizer Inc. owns 1 companies in total, including CStone Pharmaceuticals (HKSE:02616) .
Click here to see the complete history of Pfizer Inc.’s form 4 insider trades.
Insider Ownership Summary of Pfizer Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02616 | CStone Pharmaceuticals | 2020-10-09 | 2201 Interest of corporation controlled by you |
Pfizer Inc. Latest Holdings Summary
Pfizer Inc. currently owns a total of 1 stock. Pfizer Inc. owns 115,928,803 shares of CStone Pharmaceuticals (HKSE:02616) as of October 9, 2020, with a value of $277 Million.
Latest Holdings of Pfizer Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02616 | CStone Pharmaceuticals | 2020-10-09 | 115,928,803 | 2.39 | 277,069,839 |
Holding Weightings of Pfizer Inc.
Pfizer Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Pfizer Inc. has made a total of 1 transactions in CStone Pharmaceuticals (HKSE:02616) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CStone Pharmaceuticals is the sale of 0 shares on October 9, 2020, which brought Pfizer Inc. around $0.
Insider Trading History of Pfizer Inc.
- 1
Pfizer Inc. Trading Performance
Pfizer Inc. Ownership Network
Ownership Network List of Pfizer Inc.
Ownership Network Relation of Pfizer Inc.
Pfizer Inc. Owned Company Details
What does CStone Pharmaceuticals do?
Who are the key executives at CStone Pharmaceuticals?
Pfizer Inc. is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals. Other key executives at CStone Pharmaceuticals include 2101 Beneficial owner Yang Jianxin , 2201 Interest of corporation controlled by you Morgan Stanley , and 2101 Beneficial owner Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo .
CStone Pharmaceuticals (HKSE:02616) Insider Trades Summary
Over the past 18 months, Pfizer Inc. made no insider transaction in CStone Pharmaceuticals (HKSE:02616). Other recent insider transactions involving CStone Pharmaceuticals (HKSE:02616) include a net purchase of 760,500 shares made by Yang Jianxin , and a net sale of 0 shares made by Morgan Stanley .
In summary, during the past 3 months, insiders sold 0 shares of CStone Pharmaceuticals (HKSE:02616) in total and bought 560,000 shares, with a net purchase of 560,000 shares. During the past 18 months, 149,500 shares of CStone Pharmaceuticals (HKSE:02616) were sold and 910,000 shares were bought by its insiders, resulting in a net purchase of 760,500 shares.
CStone Pharmaceuticals (HKSE:02616)'s detailed insider trading history can be found in Insider Trading Tracker table.
CStone Pharmaceuticals Insider Transactions
Pfizer Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Pfizer Inc.. Currently GuruFocus does not have mailing address information for Pfizer Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
